Comments on Early Detection of Diabetes-Related Nerve Disease

NeuroMetrix, Inc. Announces Date for 2012 Second Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 second quarter financial results before the opening of the market on July 26, 2012 .

NeuroMetrix, Inc. Announces Conference Call to Discuss American Diabetes Association 72nd Scientific Sessions and Other Business Activities WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it will host a conference call at 10:00

Will Demonstrate NC-stat® DPNCheck™ and Provide First Look at SENSUS™ Pain Management Device

Initiates Campaign of Investor Outreach to Strengthen Company Awareness

NC-stat® DPNCheck&#8482 device addresses unmet medical need

Philadelphia, Pennsylvania May 23-27, 2012

Importance of Managed Care Sector is Highlighted

NeuroMetrix Announces WellMed Medical Management’s Integration of NC-stat® DPNCheck™ Into Their Patient Evaluation Program WALTHAM, Mass. --(BUSINESS WIRE)--May. 15, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the

Malvern (U.K.) Diabetic Foot Conference on May 9-12, 2012